Gil Beyen explains how Graspa works, its benefits and its other potential applications. - Gil Beyen, CEO, Erytech Pharma 00:00:00
Erytech is a French oncology company with a red blood cell encapsulation technology. Lead product Graspa has successfully completed a Phase III acute lymphoblastic leukaemia trial and a Phase IIb in acute myeloid leukaemia is ongoing, in addition to a Phase II in pancreatic cancer.